open access
Vol 15, No 1 (2012)
Other materials agreed with the Editors
Submitted: 2012-04-26
Accepted: 2012-04-26
Published online: 2012-04-24
Get Citation
On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce
Nucl. Med. Rev 2012;15(1):87.
open access
Vol 15, No 1 (2012)
Past events
Submitted: 2012-04-26
Accepted: 2012-04-26
Published online: 2012-04-24
Abstract
On 2 February 2012, Synektik SA Group officially launched theradiopharmaceuticals production in a facility which will serve thecommercial market. The project finished the two-years’ investmentby the Company which cost PLN 19 million.
Abstract
On 2 February 2012, Synektik SA Group officially launched theradiopharmaceuticals production in a facility which will serve thecommercial market. The project finished the two-years’ investmentby the Company which cost PLN 19 million.
Get Citation
About this articleTitle
On 2 February 2012, the commercial plant producing radiopharmaceuticals in Poland, developed by Synektik SA, was officially opened at Świętokrzyskie Center of Oncology in Kielce
Journal
Issue
Article type
Other materials agreed with the Editors
Pages
87
Published online
2012-04-24
Page views
828
Article views/downloads
1060
Bibliographic record
Nucl. Med. Rev 2012;15(1):87.
Authors
Dariusz Korecki
